Navigation Links
OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Date:11/5/2008

BOTHELL, WA and VANCOUVER, Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals (NASDAQ: OGXI) announced today that the Company's third quarter financial results will be released on Monday, November 10, 2008, and that the Company will host a conference call and live webcast at 4:30 p.m. EDT that afternoon. Management will discuss the company's third quarter results and provide an update on the business and product pipeline.

To access the webcast, log on to the Investor Relations page of the OncoGenex Web site at http://www.oncogenex.com. Alternatively, you may access the live conference call by dialing 877-548-7903 (U.S. & Canada) or 719-325-4917 (International). A webcast replay will be available approximately two hours after the call and will be archived on http://www.oncogenex.com for 90 days.

About OncoGenex Pharmaceuticals

OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate currently completing five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of a specific protein associated with treatment resistance; OGX-427 and SN2310 are in Phase 1 clinical development; and CSP-9222 and OGX-225 are currently in pre-clinical development. More information is available at http://www.oncogenex.com
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
2. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
3. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
4. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
5. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
6. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
7. OncoGenex increases economic interest in lead cancer drug OGX-011
8. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
9. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
10. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
11. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
(Date:12/2/2009)RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" or the "Company") (OTC Bulletin Board: EMDY), a leading,producer and distributor of infant and children,s formul
(Date:12/2/2009)The Scientist, a leading scientific magazine covering the life sciences, ranked Photometrics’ Evolve “Intelligent” EMCCD camera fourth among the publication’s “Top 10 Inn
(Date:12/1/2009)NEW YORK, Dec. 1 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Chromium - Global Market Trends ,, http://www.reportlinker.com/p0164494/Chromium--
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
...wire-FirstCall/ - SemBioSys Genetics Inc.,(TSX:SBS...of therapeutic,proteins for metabolic and cardiova...resenting a scientific poster and abstract at the ...Francisco hosted by the Diabetes,Technology Societ...mplishments in the development of a highly-scalabl...
...lence" for rEEG(SM) Application, ...., Oct. 26 CNS Response,Inc. (OTC Bulletin Board:...ntent to acquire the Neuro-Therapy Clinic, P.C., a...blished in 1993, Neuro-Therapy Clinic, P.C. is a,c... neuropsychiatric,problems, including learning, at...
...for Patient Group Task Force to Fight Growing Fake...cluding the views of bodies that,represent more th...day in,Dublin, Ireland - one of the world,s bigges...health campaigner has called for patient,groups ac... problem of fake,(counterfeit) medicines that are ...
Other Biology Technology:SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting 2CNS Response, Inc. Announces Acquisition of Neuropsychiatric Clinic 2CNS Response, Inc. Announces Acquisition of Neuropsychiatric Clinic 3Patients Fail to Take Fake Medicines Risk Seriously 2Patients Fail to Take Fake Medicines Risk Seriously 3
(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
(Date:12/2/2009)PHILADELPHIA Less acculturated Latino men have a more difficult time quitting smoking than those who are more acculturated to U.S. culture, but acculturation has no affect on Latinas odds of quitting
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Grooving down the helix 2Grooving down the helix 3Acculturation affects smoking cessation success among Latinos 2Cempra Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 6531 1Feeding the clock 10896 1Feeding the clock 10896 2Feeding the clock 10896 3Pari Beauty Professional Artistry 62106 1Pari Beauty Professional Artistry 62106 2
... , , , , , , , ... , This recording demonstrates the progression ...in two tutoring lineages and also in the isolate c...formation. , , , , , ,... , , , , , , NEW YORK, May 3, 2009 In ...
...researchers describe a breakthrough in safe and ef...s small interfering RNA (siRNA) molecules that si...w kind of treatment for sexually transmitted disea...ce online publication of Nature Materials . , "R...tion and treatment of human disease," said lead au...
...eted therapies are beginning to offer new treatmen...y stages of lung cancer, experts said at the first... Oncology (EMCTO) in Lugano, Switzerland (1-3 May ...gy for longer and better survival in lung cancer,"...cal Oncology Department at Hygeia Hospital in Athe...
Other Biology News:CCNY, CSHL biologists find birdsong of isolates reverts to norm over several generations 2CCNY, CSHL biologists find birdsong of isolates reverts to norm over several generations 3Nanotechnology holds promise for STD drug delivery 2Personalized treatment for early lung cancer 2
Goat Anti-Human UBN-1 (C-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rat Anti-Mouse HAI-1 Ectodomain Monoclonal Antibody, Unconjugated, Clone 199732 from R&D Systems
Goat Anti-Human IL-29 / IFN-lambda 1 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Rabbit Anti-Rat Potassium Channel EAG-1 Antibody, Unconjugated from CHEMICON
Biology Products: